Logo image of ZTEK

ZENTEK LTD (ZTEK) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:ZTEK - CA98942X1024 - Common Stock

0.841 USD
-0.03 (-3.56%)
Last: 1/16/2026, 8:00:02 PM
0.8658 USD
+0.02 (+2.95%)
After Hours: 1/16/2026, 8:00:02 PM

ZTEK Key Statistics, Chart & Performance

Key Statistics
Market Cap90.25M
Revenue(TTM)915.30K
Net Income(TTM)-8.20M
Shares107.31M
Float101.45M
52 Week High1.84
52 Week Low0.62
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.06
PEN/A
Fwd PEN/A
Earnings (Next)02-11
IPO2010-12-22
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
ZTEK short term performance overview.The bars show the price performance of ZTEK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15 20 25

ZTEK long term performance overview.The bars show the price performance of ZTEK in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of ZTEK is 0.841 USD. In the past month the price increased by 24.59%. In the past year, price decreased by -28.72%.

ZENTEK LTD / ZTEK Daily stock chart

ZTEK Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to ZTEK. When comparing the yearly performance of all stocks, ZTEK is a bad performer in the overall market: 78.35% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ZTEK Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ZTEK. Both the profitability and financial health of ZTEK have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ZTEK Financial Highlights

Over the last trailing twelve months ZTEK reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 26.08% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -48.58%
ROE -70.13%
Debt/Equity 0.15
Chartmill High Growth Momentum
EPS Q2Q%23.75%
Sales Q2Q%-60.51%
EPS 1Y (TTM)26.08%
Revenue 1Y (TTM)2223.1%

ZTEK Forecast & Estimates


Analysts
Analysts84.44
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

ZTEK Ownership

Ownership
Inst Owners1.71%
Ins Owners0.78%
Short Float %0.06%
Short Ratio1.09

About ZTEK

Company Profile

ZTEK logo image Zentek Ltd. engages in the research, development, and commercialization of graphene-based novel products. The company is headquartered in Guelph, Ontario and currently employs 17 full-time employees. The company went IPO on 2010-12-22. The firm is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The firm is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The firm has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The firm is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.

Company Info

ZENTEK LTD

24 Corporate Ct

Guelph ONTARIO CA

Employees: 17

ZTEK Company Website

ZTEK Investor Relations

Phone: 18447309822

ZENTEK LTD / ZTEK FAQ

Can you describe the business of ZENTEK LTD?

Zentek Ltd. engages in the research, development, and commercialization of graphene-based novel products. The company is headquartered in Guelph, Ontario and currently employs 17 full-time employees. The company went IPO on 2010-12-22. The firm is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The firm is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The firm has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The firm is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.


Can you provide the latest stock price for ZENTEK LTD?

The current stock price of ZTEK is 0.841 USD. The price decreased by -3.56% in the last trading session.


What is the dividend status of ZENTEK LTD?

ZTEK does not pay a dividend.


How is the ChartMill rating for ZENTEK LTD?

ZTEK has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Should I buy ZTEK stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ZTEK.


How many employees does ZENTEK LTD have?

ZENTEK LTD (ZTEK) currently has 17 employees.


Can you provide the short interest for ZTEK stock?

The outstanding short interest for ZENTEK LTD (ZTEK) is 0.06% of its float.